Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)
Clinical trial NCT00759109 · COMPLETED
Trial details
- NCT number
- NCT00759109
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-01
- Primary completion
- 2009-11-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.